Stanford University

Fluxion Biosciences, Stanford collaborate on circulating tumor cell analysis

Friday, June 29, 2012 11:45 AM

Fluxion Biosciences, a San Francisco-based provider of cellular analysis tools for use in critical life science, has formed a collaboration with the Stanford University School of Medicine to develop tests to help deliver more effective therapies to cancer patients.

More... »

Editors: FDA medical-device approval studies flawed

Friday, July 22, 2011 10:10 AM

Studies concluding U.S. reviews of medical devices lag behind those in Europe and drive up costs for makers are flawed, according to editors of three medical journals, Bloomberg News reported.

More... »

Point-of-care clinical trials integrate standard trial procedures into routine clinical care

Monday, May 2, 2011 08:00 AM

Doctors at the Veterans Affairs Boston Healthcare System are testing a new clinical trials method that allows researchers to compare the effectiveness of two standard diabetes treatments without spending the cost and time needed to conduct a traditional double-blind, placebo-controlled trial.

More... »

Stanford University creates drug development technology

Thursday, April 28, 2011 12:44 PM

Stanford University has created a new biosensor microchip that can speed up drug development with the help of more than 100,000 magnetically-sensitive nanosensors that can analyze how proteins bond, according to FierceBiotechResearch.

More... »

Stanford and SanBio initiate trial for stroke patients

Monday, April 25, 2011 12:53 PM

The Stanford University School of Medicine and SanBio, a San Francisco biotechnology company focused on the discovery and development of regenerative cell therapy products, have initiated a phase 1/2a clinical trial testing the safety and efficacy of an allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.

More... »

Sanofi-aventis collaborates with Stanford University

Monday, April 18, 2011 12:49 PM

Sanofi-aventis has entered into a research collaboration agreement that will last several years through the Stanford University Bio-X program, according to Fierce Biotech.  The Stanford program supports, organizes, and facilitates interdisciplinary, collaborative and innovative research projects in the early phases of development.

More... »